Quantum Biopharma Ltd (QNTM) Stock Price, Quote & News

Company Profile

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is...

Industry: Biotechnology

Sector: Healthcare

Phone: 833 571 1811

Website: www.quantumbiopharma.com

Address:

55 University Avenue, Suite 1003, Toronto, Canada

FickleFin Jan. 21 at 2:43 PM

$QNTM this douche canoe is about to stir the pot... No response. So now we get confrontational. LMFAO.

0 · Reply

FickleFin Jan. 21 at 2:42 PM

$QNTM "hopefully" .... Milestones are never reached. For someone that states he doesn't have time to be all over the internet, he quite sure is all over twitter asking for HELP. Always states one thing does another. Phase 2 has been due for a long time.. desperation reeks. 🥴

0 · Reply

FickleFin Jan. 20 at 12:33 PM

$QNTM you can make more money shorting this stock. Management and bod still dwelling on the spoofing case even though they know it's going "NOWHERE." The same excuses with no results. UNBUZZD is dead. MS trials no updates and when there is... It's a stupid press release. Management has been grifting off in investors for years promising milestones that are never finished. Then you get loopholes, dilution, reverse splits and broken promises. If you take out the smoke and noise you see the FRAUD. 📉

0 · Reply

FickleFin Jan. 16 at 1:46 PM

$QNTM if your still investing in this stock you deserve to lose your $$$. Financials and repeat scenarios.

0 · Reply

Wearewhowethought Jan. 14 at 4:03 PM

$BTC.X $AABB $GNS $QNTM

0 · Reply

Wearewhowethought Jan. 14 at 3:25 PM

$BTC.X $AABB $GNS $QNTM

1 · Reply

Wearewhowethought Jan. 14 at 3:03 PM

$BTC.X $AABB $GNS $QNTM

0 · Reply

SomeWhereInTime777 Jan. 14 at 2:55 PM

$GNS $BTC.X $QNTM Time to engage some elevated GNS price action discovery reflection. BTC on the rise! 🧘🏻‍♂️🧘🏻‍♂️🙏🏼💪🏼🙏🏼🙏🏼🧘🏻‍♂️

0 · Reply

Youn1 Jan. 14 at 2:34 PM

And let’s not forget $MULN.X. $MULN.X’s spoofing case, filed in December 2023, a federal judge denied the motion to dismiss, sending the case into full discovery after years of alleged algorithmic spoofing by major market makers. And that’s just one of several manipulation-related lawsuits (like $GNS, $QNTM, $AABB, $MMTLP).When the legal system keeps validating these claims, that says something about the market.

0 · Reply

Wearewhowethought Jan. 14 at 2:34 PM

$BTC.X $AABB $GNS $QNTM they then leverage the brokers to turn of buy buttons and say ”well just say its compliance, or the company may be a scam” then they create bad news and try to cover or Bk rhe company yet thousands of companies and shitty coins trade free without having to call in. they dont shut the buy button down when the stock is going up they shut it down on the way down when there major clients need to cover

0 · Reply

Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)

Dec 10, 2025, 8:00 PM EST - 5 weeks ago

Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update

Nov 27, 2025, 4:00 PM EST - 7 weeks ago

Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC

Nov 26, 2025, 9:30 AM EST - 2 months ago

Quantum Biopharma's USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5

Nov 7, 2025, 7:00 AM EST - 2 months ago

Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern' Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio

Oct 31, 2025, 7:51 PM EDT - 2 months ago

Quantum BioPharma Ltd. Provides Corporate Update

Oct 29, 2025, 9:00 PM EDT - 2 months ago

Quantum BioPharma Ltd. Announces Corporate Updates

Oct 23, 2025, 8:15 AM EDT - 3 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication

Oct 20, 2025, 8:30 AM EDT - 3 months ago

Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend

Oct 14, 2025, 8:15 AM EDT - 3 months ago

Quantum BioPharma Ltd. Responds to Vague and Misleading Allegations by The Schall Law Firm and DJS Law Group

Oct 9, 2025, 6:00 PM EDT - 3 months ago

Quantum BioPharma Ltd. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QNTM

Oct 9, 2025, 5:40 PM EDT - 3 months ago

QNTM Investors Have Opportunity to Join Quantum BioPharma Ltd. Fraud Investigation with the Schall Law Firm

Oct 8, 2025, 8:00 AM EDT - 3 months ago

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Oct 7, 2025, 11:00 AM EDT - 3 months ago

Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View

Oct 3, 2025, 7:00 AM EDT - 3 months ago

Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case

Oct 2, 2025, 7:57 AM EDT - 3 months ago

Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial

Oct 1, 2025, 7:50 AM EDT - 4 months ago

Quantum BioPharma Welcomes World-Renowned Multiple Sclerosis Expert Dr. Jack Antel as Clinical Development Advisor For Lucid-MS Trials

Sep 29, 2025, 7:40 AM EDT - 4 months ago

Quantum BioPharma Ltd. Announces Results of Annual General and Special Meeting of Shareholders

Sep 26, 2025, 8:00 PM EDT - 4 months ago

Quantum BioPharma Announces Corporate Updates

Sep 24, 2025, 8:30 AM EDT - 4 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar and Q&A Session on Wednesday, October 1, 2025

Sep 18, 2025, 8:10 AM EDT - 4 months ago

Health Canada Grants Quantum BioPharma a Product License for Its Innovative Product, Qlarity™, that Enhances Energy, and Promotes Metabolism, Mental Alertness and Cognitive Performance

Sep 12, 2025, 7:50 AM EDT - 4 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PT

Sep 10, 2025, 7:00 AM EDT - 4 months ago

Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target

Aug 11, 2025, 6:32 PM EDT - 5 months ago

Quantum BioPharma Announces Update to Previously Announced Private Placement

Aug 11, 2025, 7:40 AM EDT - 5 months ago

Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial

Aug 8, 2025, 8:00 AM EDT - 5 months ago

Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients

Aug 7, 2025, 7:00 AM EDT - 5 months ago

Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of date of filing, and Near Elimination of Debt

Aug 5, 2025, 7:34 AM EDT - 6 months ago

Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)

Aug 4, 2025, 7:33 AM EDT - 6 months ago

Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing

Jul 31, 2025, 7:24 AM EDT - 6 months ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO

Jul 30, 2025, 4:00 PM EDT - 6 months ago

Quantum BioPharma Shares' Rollercoaster Day: What's Going On?

Jul 22, 2025, 7:00 AM EDT - 6 months ago

Quantum BioPharma Makes Strategic Investment in GameStop Corp.

GME

Jun 27, 2025, 4:30 PM EDT - 7 months ago

Quantum BioPharma Announces Private Placement

Jun 26, 2025, 7:30 AM EDT - 7 months ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering

Jun 18, 2025, 9:19 AM EDT - 7 months ago

Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress

Jun 17, 2025, 8:00 AM EDT - 7 months ago

Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital

Jun 13, 2025, 7:00 AM EDT - 7 months ago

Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds

Jun 3, 2025, 7:50 AM EDT - 8 months ago

Quantum BioPharma Clarifies It Has Not Changed Its Name

Jun 2, 2025, 1:47 PM EDT - 8 months ago

iNGENū CRO Partners with Quantum BioPharma to Launch Pioneering Australian Clinical Trial for Chronic Nociplastic Pain in MCAS Patients

May 30, 2025, 7:00 AM EDT - 8 months ago

Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari

May 29, 2025, 7:30 AM EDT - 8 months ago

Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc.

May 28, 2025, 8:00 AM EDT - 8 months ago

Quantum BioPharma Receives Ethics Committee Approval for Phase 2 Clinical Trial of FSD202 for Nociplastic Pain in Patients with Idiopathic Mast Cell Activation Syndrome

May 20, 2025, 7:30 AM EDT - 8 months ago

Quantum Biopharma Announces Signing of an Agreement with a Global Pharmaceutical Contract Research Organization to Prepare an IND (Investigational New Drug) Application Package for Lucid-21-302 (Lucid-MS), A First-In-Class Treatment for Multiple Sclerosis

May 19, 2025, 7:30 AM EDT - 8 months ago

Quantum Biopharma Purchases an Additional USD $1 Million of Bitcoin and Other Cryptocurrencies to Hold BTC Treasury and To Generate Staking Revenue. Bringing the Total Investment in Digital Assets to USD $4,500,000

May 16, 2025, 7:30 AM EDT - 8 months ago

Quantum BioPharma to Attend Sidoti Micro-Cap Investor Conference and the AGP Virtual Healthcare Conference

May 12, 2025, 8:00 AM EDT - 9 months ago

Quantum BioPharma Announces Completion of Dosing in 90-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-MS for Multiple Sclerosis

May 6, 2025, 8:25 PM EDT - 9 months ago

Quantum BioPharma Ltd. (QNTM) Business Update Conference Call Transcript

May 5, 2025, 7:08 AM EDT - 9 months ago

Quantum Biopharma Files Amended Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing

Apr 24, 2025, 7:00 AM EDT - 9 months ago

Quantum BioPharma to Host Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m. Eastern Time

Apr 22, 2025, 7:00 AM EDT - 9 months ago

Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin Malone Appointed as Board Advisor

FickleFin Jan. 21 at 2:43 PM

$QNTM this douche canoe is about to stir the pot... No response. So now we get confrontational. LMFAO.

0 · Reply

FickleFin Jan. 21 at 2:42 PM

0 · Reply

FickleFin Jan. 20 at 12:33 PM

0 · Reply

FickleFin Jan. 16 at 1:46 PM

$QNTM if your still investing in this stock you deserve to lose your $$$. Financials and repeat scenarios.

0 · Reply

Wearewhowethought Jan. 14 at 4:03 PM

$BTC.X $AABB $GNS $QNTM

0 · Reply

Wearewhowethought Jan. 14 at 3:25 PM

$BTC.X $AABB $GNS $QNTM

1 · Reply

Wearewhowethought Jan. 14 at 3:03 PM

$BTC.X $AABB $GNS $QNTM

0 · Reply

SomeWhereInTime777 Jan. 14 at 2:55 PM

$GNS $BTC.X $QNTM Time to engage some elevated GNS price action discovery reflection. BTC on the rise! 🧘🏻‍♂️🧘🏻‍♂️🙏🏼💪🏼🙏🏼🙏🏼🧘🏻‍♂️

0 · Reply

Youn1 Jan. 14 at 2:34 PM

0 · Reply

Wearewhowethought Jan. 14 at 2:34 PM

0 · Reply

Wearewhowethought Jan. 14 at 2:28 PM

$BTC.X $AABB $GNS $QNTM these companies ALL need to join together

0 · Reply

Wearewhowethought Jan. 14 at 2:27 PM

$BTC.X $AABB $GNS $QNTM is time to research all other companies going after these guys.

0 · Reply

Wearewhowethought Jan. 14 at 2:22 PM

$BTC.X $AABB $GNS $QNTM lawsuit in the United States District Court for the Central District of California against Virtu Financial Inc., GTS Securities LLC (MPID: GTSM), and G1 Execution Services LLC, for securities fraud and coordinated market manipulation of Asia Broadband’s publicly traded stock symbol AABB. Based on daily comprehensive, real-time, deceitful, market maker behavior captured over multiple years they have done this to hundreds of companies. how do you think kenny can buy all of palm beach? Bitcoin treasury is the savior here and bitcoin run. they will break they borrowed from japan at zero they cant get out of the shorts. once one of the above breaks out on lawsuit they all should

0 · Reply

Wearewhowethought Jan. 14 at 2:12 PM

$BTC.X $AABB $GNS $QNTM here they are again. citadel, virtue , gst all gaming the system and stealing billions from retail along the way 7 lawsuits pedning now https://law.justia.com/cases/federal/district-courts/new-york/nysdce/1:2022cv10185/590344/188/

0 · Reply

Wearewhowethought Jan. 14 at 2:08 PM

$BTC.X $AABB $GNS $QNTM #3 https://www.quiverquant.com/news/Quantum+BioPharma+Ltd.+Faces+Class+Action+Lawsuit+Over+Allegations+of+Stock+Manipulation

0 · Reply

Wearewhowethought Jan. 14 at 2:06 PM

$BTC.X $AABB $GNS $QNTM #2 https://www.businesswire.com/news/home/20251117989078/en/Grant-Eisenhofer-Files-Class-Action-Lawsuit-Against-Citadel-Securities-LLC-and-Virtu-Americas-LLC

0 · Reply

Wearewhowethought Jan. 14 at 2:05 PM

$BTC.X $AABB $GNS $QNTM the 4th lawsuit against Virtu and citadel in 3 months. $GNS these firms illegally attacked hundreds of companys to short to BK and never cover and pay cap gains. stealing billions. Gns group started recording 3 years ago. and had 750 million in pending litigation to collect. the hedge funds then convince the brokers to turn the buy button off and only allow you to call buys in to suppress the price and allow them to cover. retail needs to join the fight call it in. they squeeze on buy pressure. These funds will fall and as soon as one lawsuit wins they should all run. im leveraging to grab some of each. 5 companies with 7 national lawsuits accusing citadel and virtu of the same things are not pulling it out of there ass gns only has minimal float and trades 400k a day and a month agao 70 million ore matket https://www.barchart.com/story/news/37016816/asia-broadband-inc-pursues-250-million-dollars-in-total-damages-from-market-makers-in-federal-lawsuit-filed-for-coordinated-market-manipulation-and-securities-fraud

1 · Reply

Yardwisperer Jan. 13 at 8:30 PM

$AABB $GNS $QNTM $NWBO $MMTLP AND TOO MUCH THEFT OF RETAIL INVESTORS $$$$$

2 · Reply

Youn1 Jan. 13 at 8:09 PM

Another lawsuit. Same names. $AABB joins $GNS $QNTM $NWBO $MMTLP in suing Virtu for market manipulation. Too many cases. Too consistent. Too ignored. This is a real problem and it’s coming to light.

5 · Reply

FickleFin Jan. 8 at 3:21 AM

$QNTM another alias created by Malone... Reposting his threat, this time tagging the bod from the shitco... 😂 Highly entertaining.

0 · Reply

FickleFin Jan. 8 at 3:09 AM

$QNTM this idiot is also Kevin Malone...

0 · Reply

EatingWithSpork Jan. 7 at 1:32 PM

$QNTM what a clown! Did he seriously threaten to weaponize his clients as an ultimatum to get rehired after getting fired?! LMAO! 🤣🤣🤣

1 · Reply

Market Cap	26.91M
Revenue (ttm)	0.00
Net Income (ttm)	-14.20M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	82,500
Avg Vol	111,006
Day's Range	N/A - N/A
Shares Out	3.82M
Stochastic %K	46%
Beta	0.24
Analysts	Sell
Price Target	$35.50